Instrument Fundamentals
| Date | Close | Change | Change (%) | Open | High | Low |
|---|
News
Aurora Cannabis (OTCMKTS:ACBFF) Shares Down 6.7% - What's Next? - Zolmax
Why Didn't Tilray Brands Make a Bid for Aurora Cannabis? - AOL
Reviewing Pacira BioSciences (NASDAQ:PCRX) and Aurora Cannabis (NASDAQ:ACB) - Stock Observer
Promising Cannabis Stocks To Add to Your Watchlist - November 15th - Daily Political
3 Canadian Healthcare Stocks With Up To 30% Revenue Growth
Organigram (NASDAQ: OGI) agrees to buy Aurora Cannabis in a cash-and-share deal - Daily Political
Best Cannabis Stocks To Research - November 11th
Curaleaf Holdings (TSX:CURA) Clears Key Hurdle As Its Cannabis Deal Nears Closing
Cannabis Stocks To Watch Now - November 9th - Daily Political
Weekly Roundup on the Cannabis Sector & Psychedelic Sector
Which of These 5 Cannabis Stocks Has the Strongest Balance Sheet?
Organigram (NASDAQ: OGI) agrees to buy Aurora at a 93% premium, topping Curaleaf - Markets Daily
Aurora Cannabis And 2 Other Canadian Healthcare Stocks To Own
Aurora Cannabis (TSE:ACB) Releases Quarterly Earnings Results - Stock Observer
Organigram (NASDAQ: OGI) agrees to buy Aurora at a 93% premium, topping Curaleaf - Daily Political
Aurora Cannabis Inc. (ACB) - What Are Investment Firms Saying About This Stock?
Aurora Cannabis (TSE:ACB) Rating Lowered to "Strong Sell" at TD Securities - Zolmax
Aurora Cannabis Inc. Q2 Loss Drops
Aurora Cannabis (NASDAQ:ACB) Rating Lowered to Strong Sell at TD Securities
Aurora Cannabis (TSE:ACB) Cut to Strong Sell at TD Securities - Markets Daily
Aurora Cannabis (TSE:ACB) Stock Rating Cut to "Strong Sell" at TD Securities - Stock Observer
Aurora Cannabis (ACB) Q2 2027 Earnings Date, Time & Estimates
Aurora Cannabis (TSE:ACB) Stock Gets Downgrade from TD
Cannabis Stocks To Keep An Eye On - November 4th - Stock Observer
Aurora Cannabis (TSE:ACB) Rating Lowered to Sell at TD - Daily Political
Organigram-Aurora $561 million deal taps Goodmans, Torys, Stikeman Elliott, Paul Weiss
Investors' concerns about the AI trade - BNN Bloomberg
Organigram to acquire Aurora Cannabis topping Curaleaf hostile bid - BNN Bloomberg
Curaleaf Issues Statement Regarding Alternative Proposal for Aurora Cannabis
Aurora Cannabis (TSE:ACB) Stock Price Up 19.9% - Time to Buy?
Organigram To Acquire Aurora Cannabis In C$561 Mln Deal
Organigram Swoops In To Acquire Aurora Cannabis, Topping Curaleaf's Rival Bid - ACB Stock Surges To Over 10-Month Highs
Organigram signs friendly deal to buy Aurora Cannabis after hostile Curaleaf offer
Organigram to Acquire Aurora and Establish a Global Cannabis Leader
Organigram Strikes A Deal to Acquire Aurora Cannabis
Canadian Investment Regulatory Organization Trade Resumption - ACB
Top Cannabis Stocks To Keep An Eye On - November 3rd - Stock Observer
Aurora Cannabis (TSE:ACB) Shares Climb 19.9% - Should You Buy? - Daily Political
Top Cannabis Stocks To Keep An Eye On - November 2nd - Stock Observer
Cannabis Stocks To Follow Today - October 31st - Markets Daily
Best Cannabis Stocks To Watch Today - October 29th - Daily Political
Cannabis Stocks To Follow Today - October 31st - Stock Observer
Top 3 Canadian Healthcare Stocks To Watch In October 2026
Best Cannabis Stocks To Follow Today - October 30th - Stock Observer
Aurora Cannabis to Host Second Quarter 2027 Investor Conference Call
Aurora Cannabis (TSE:ACB) Stock Crosses Above Fifty Day Moving Average - Time to Sell?
Aurora Cannabis (TSE:ACB) Stock Price Up 5.8% - Still a Buy?
Aurora Cannabis (TSE:ACB) Share Price Breaks Above Fifty Day Moving Average - Here's Why - Daily Political
Top Cannabis Stocks To Consider - October 27th - Stock Observer
3 Canadian Healthcare Stocks With Revenue Growth Over 7%
Cannabis Stocks To Watch Now - October 22nd - Stock Observer
Aurora Cannabis (NASDAQ:ACB) & BioAge Labs (NASDAQ:BIOA) Head to Head Comparison - Stock Observer
Aurora news
Latest news
Show more
Global Market Review: Gold Volatility and Tech Stock Surge Amidst Economic Uncertainty
September CPI Data: Inflation Hurdles, Tariff Impacts, and Fed Rate Cut Expectations
Navigating the AI Boom: Strategies for Investors Amid Nvidia's Valuation Surge
